Combined with the decreased PTGS2 expression level we found in the above-mentioned DN patients; it is partially confirmed that the decreased PTGS2 levels in DN patients may be related to the enhanced activation of the immune system. Here, PTGS2 is linked to liver dysplastic nodule.